CS

Chakravarthy Sriraman Mandayam

Active Director Director DIN 09631555
DIN 09631555 First appointment Jun 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Chakravarthy Sriraman Mandayam

Data last updated:

Chakravarthy Sriraman Mandayam is a Director at Concord Biotech Limited (since 2022). The company operates in Chemicals. Concord Biotech Limited reported revenue of ₹888 Cr (FY 2023).

DIN 09631555
Primary Designation Director
Industry Chemicals
First Appointment 14 Jun 2022
Oldest Company Age 41 yrs
Largest company Concord Biotech Limited · ₹888 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Concord Biotech Limited L24230GJ1984PLC007440
Director14 Jun 20221984₹888 Cr (FY 2023)Active

Board colleagues of Chakravarthy Sriraman Mandayam

Directorship timeline

Open interactive timeline →
Concord Biotech Limited
Premium access

Shareholding and investment profile for Chakravarthy Sriraman Mandayam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chakravarthy Sriraman Mandayam

Chakravarthy Sriraman Mandayam currently holds 1 directorship: Concord Biotech Limited (Director, since 14 Jun 2022, revenue ₹888 Cr (FY 2023)).

Chakravarthy Sriraman Mandayam was first appointed on 14 Jun 2022 as Director at Concord Biotech Limited.

The current boards of Chakravarthy Sriraman Mandayam's companies include Amitabh Gajendra Thakore (Concord Biotech Limited), Ankur Vaid (Concord Biotech Limited), Arvind Motilal Agarwal (Concord Biotech Limited), Bharti Khanna (Concord Biotech Limited), Ekta Gupta (Concord Biotech Limited), Jayaram Easwaran (Concord Biotech Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available